Role of RNAaemia and the Immunopathology of Moderate-to-Severe COVID
A Viewpoint article published in The Lancet Rheumatology proposed that different presentations of COVID-19 may require varied approaches for treatment.
Read More »
Long COVID
Vaccination Reduces Risk of Long COVID by 49%
According to a study published in The Lancet Infectious Diseases, those who are fully vaccinated against COVID-19 are 49% less likely to develop Long Covid in the unlikely event they contract COVID-19.
Read More »Cognitive Consequences of COVID
A recent study conducted in the UK sought to confirm whether there was an association between cognitive performance data from 81,337 participants and COVID-19 case data.
Read More »Influence of Sex Hormones on Long COVID
Recent scientific discussion has correlated Long Covid with estrogen-associated autoimmune disease. There has yet to be a consensus on the definition of “Long Covid.” That being said, it is widely acknowledged that Long Covid symptoms, including shortness of breath, persistent fatigue, brain fog, and GI disturbances, typically last more than 2 months after a COVID-19 infection. “Women appear to be twice as likely to develop Long Covid as men, but only until around age 60, when the risk level becomes similar.”
Read More »